Log In
BCIQ
Print this Print this
 

URC102

  Manage Alerts
Collapse Summary General Information
Company Chugai Pharmaceutical Co. Ltd.
DescriptionURAT1 inhibitor
Molecular Target Solute carrier family 22 organic anion urate transporter member 12 (SLC22A12) (URAT1)
Mechanism of ActionSolute carrier family 22 organic anion urate transporter member 12 (SLC22A12) (URAT1) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationHyperuricemia / gout
Indication DetailsTreat gout
Regulatory Designation
PartnerJW Pharmaceutical Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today